High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens.
High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens.
复制标题
DOI:
10.4049/jimmunol.155.10.4838
复制
发表时间:
1995-11
影响因子:
4.4
通讯作者:
B. Rutledge;H. Rayburn;R. Rosenberg;R. North;R. Gladue;C. Corless;B. Rollins
中科院分区:
文献类型:
--
作者:
B. Rutledge;H. Rayburn;R. Rosenberg;R. North;R. Gladue;C. Corless;B. Rollins
We have constructed transgenic mice in which the mouse mammary tumor virus long terminal repeat controls the expression of murine monocyte chemoattractant protein-1 (MCP-1). Several independently derived lines of transgenic mice constitutively expressed MCP-1 protein in a variety of organs. Protein extracts from these organs had substantial in vitro monocyte chemoattractant activity that was neutralized by an anti-MCP-1 Ab, indicating that transgenic MCP-1 protein is biologically active. However, no transgenic mouse at any age displayed monocyte infiltrates in MCP-1-expressing organs. Two transgenic lines had circulating MCP-1 levels of 13 to 26 ng/ml, which is a concentration sufficient to induce maximal monocyte chemotaxis in vitro. These transgenic lines showed a 1 to 1.5 log greater sensitivity to infection with Listeria monocytogenes and Mycobacterium tuberculosis. A third transgenic line had lower serum levels of MCP-1 and was resistant to L. monocytogenes. The results suggest that this transgenic model is one of monocyte nonresponsiveness to locally produced MCP-1 due to either receptor desensitization or neutralization of a chemoattractant gradient by high systemic concentrations of MCP-1. Regardless of the mechanism, the data indicate that constitutively high levels of MCP-1 expression do not induce monocytic infiltrates, and that MCP-1 is involved in the host response to intracellular pathogens.